Search Results - "Gibson, Amber"

Refine Results
  1. 1
  2. 2
  3. 3
  4. 4

    Frontline Venetoclax Therapy for 18-Year-Old Male with Ataxia Telangiectasia and Early T-Cell Precursor Acute Lymphoblastic Leukemia by Alqahtani, Shaikha, Ramakrishnan, Ramya, Nunez, Cesar, McCall, David, Garcia, Miriam B., Cuglievan, Branko, Gibson, Amber

    Published in Blood (02-11-2023)
    “…Ataxia Telangiectasia (AT) is an autosomal recessive disorder which is associated with progressive neurodegeneration, immunodeficiency, and predisposition to…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7

    RARE-44. CLINICAL CHARACTERIZATION AND OUTCOME; OUR EXPERIENCE OF CHORDOMAS IN PEDIATRIC AND YOUNG ADULTS by Gibson, Amber, Baig, Muhammad, Raza, Shaan, Grosshans, David, Zaky, Wafik

    Published in Neuro-oncology (Charlottesville, Va.) (04-12-2020)
    “…Abstract Pediatric chordomas are exceedingly rare and there are limited data to guide treatment decisions. We report a retrospective analysis of 19 patients…”
    Get full text
    Journal Article
  8. 8

    Venetoclax for pediatric patients with newly diagnosed acute myeloid leukemia by Gibson, Amber, Dickson, Samantha, McCall, David, Garcia, Miriam, Connors, Jeremy, He, Jiasen, Roth, Michael, Nunez, Cesar, Cuglievan, Branko

    Published in Pediatric blood & cancer (01-11-2024)
    “…This retrospective study at the University of Texas MD Anderson Cancer Center evaluated frontline venetoclax combination therapy in 11 pediatric/adolescent…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Once-daily Compared With Twice-daily Enoxaparin Maintenance Therapy Appears Safe and Efficacious in Pediatric Venous Thromboembolism by Gibson, Amber, Montanez, Natalie, Addy, Katherine, Hashmi, S. Shahrukh, Brown, Deborah, Rodriguez, Nidra, Menon, Neethu, Srivaths, Lakshmi

    Published in Journal of pediatric hematology/oncology (01-07-2023)
    “…Once-daily enoxaparin (ODE), considered standard of care for venous thromboembolism (VTE) treatment in adults, has been infrequently assessed in children. To…”
    Get full text
    Journal Article
  11. 11
  12. 12

    EAPH-15. COMBINATION THERAPY WITH VINCRISTINE, IRINOTECAN, AND TEMOZOLOMIDE IN CENTRAL NERVOUS SYSTEM MALIGNANCIES by Gibson, Amber, Bavle, Abhishek, Gross, Naina, Gavula, Theresa, McNall, Rene

    Published in Neuro-oncology (Charlottesville, Va.) (22-06-2018)
    “…Abstract Current therapeutic options for high grade gliomas including DIPG (HGG) and relapsed or refractory CNS malignancies (R-CNS), excluding low grade…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15
  16. 16

    Non‐myeloablative umbilical cord blood transplantation for atypical dyskeratosis congenita by Gibson, Amber, Ragoonanan, Dristhi, Tewari, Priti, Petropoulos, Demetrios, Rodriguez, Nidra, DiNardo, Courtney, Mahadeo, Kris M., Khazal, Sajad

    Published in Pediatric transplantation (01-03-2022)
    “…Background Short telomere syndrome (STS) in children may result in phenotypically heterogenous clinical spectrum ranging from completely asymptomatic to…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Pembrolizumab in Combination with Antigen-Specific Cytotoxic T Lymphocytes Enhances Killing of Acute Myeloid Leukemia by Gibson, Amber, Zhang, Mao, Sukhumalchandra, Pariya, Philips, Anne V., Qiao, Na, Perakis, Alexander A., Kerros, Celine, St. John, Lisa, Clise-Dwyer, Karen, Lu, Sijie, Ma, Qing, Molldrem, Jeffrey J., Alatrash, Gheath

    Published in Blood (23-11-2021)
    “…Background Pembrolizumab, an antibody that blocks programmed cell death protein 1 (PD-1), has been FDA approved for several solid tumors and hematologic…”
    Get full text
    Journal Article
  19. 19

    Frontline Hyper-CVAD Plus Venetoclax for Pediatric Blastic Plasmacytoid Dendritic Cell Neoplasm by He, Jiasen, Garcia, Miriam B., Connors, Jeremy S., Nuñez, Cesar A., Quesada, Andres E., Gibson, Amber, Roth, Michael, Cuglievan, Branko, Pemmaraju, Naveen, McCall, David

    Published in Journal of pediatric hematology/oncology (01-11-2023)
    “…Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare hematologic malignancy, especially in pediatrics, that can involve the bone marrow, skin, lymph…”
    Get full text
    Journal Article
  20. 20